R-V Industries is taking significant strides in the pharmaceutical market. With its upcoming participation in key industry ...

Given the present uncertainty, we need to wait and watch on how the tariff situation evolves. However, it is likely that in ...

Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030 In 2023, ...

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...

Driven by its Pharmaceutical Activities, Roquette's 2024 Results Demonstrate the Resilience of its Integrated Business Model ...

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, BMRN should be on investors' short list. Should You Invest in BioMarin Pharmaceutical Inc. (BMRN)? Before you invest in BioMarin ...

Yes. Bernard Birkett, CFO, West Pharmaceutical Services: I just think the important point is that we are seeing that growth in our HVP like mid single, high single digit growth that we talked ...

Sun Pharmaceutical Industries Limited has announced the completion of its 100% acquisition of Antibe Therapeutics Inc., a ...

The Germany pharmaceutical intermediate market is set for significant expansion, with projections estimating a market value of USD 1,729.8 million in 2025, growing to USD 2,394.7 million by 2035. This ...